Clinical Trial

Optimal Treatment Protocol for Selective Laser Trabeculoplasty

Study acronym: OSLT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A randomized controlled trial to evaluate which treatment protocol in selective laser trabeculoplasty that is most optimal in terms of efficacy and safety.
Protocol Amendment History 1 change
notable Primary completion moved earlier: 2027-12-31 -> 2026-04-30 2026-07-31
Trial Details
NCT Number NCT03798223
Lead Sponsor Vastra Gotaland Region
Collaborators: Göteborg University
Conditions Glaucoma, Open-Angle, Pseudoexfoliation Glaucoma, Ocular Hypertension
Enrollment 400 participants
Start Date 2019-01-10
Primary Completion 2026-04-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30